China Industrial Asset Management Leads $40M Series C1 Round In Chinese Cancer Immunotherapy Company

Login to View
(Alex_Traksel - stock.adobe.com) est tubes closeup on blue background..medical glassware

Chinese cancer immunotherapy company Shanghai Cell Therapy Group Co. has raised RMB275 million (US$39.60 million) in series C1 round of financing from private equity firm China Industrial Asset Management Limited. 

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS